NRX Pharmaceuticals (NRXP) Return on Invested Capital (2021 - 2025)
NRX Pharmaceuticals (NRXP) posted quarterly Return on Invested Capital of 0.13% for Q3 2025, up 3.0% year-over-year from 0.12% in Q3 2024, and up 20.84% quarter-over-quarter from 0.16% in Q3 2024.
NRX Pharmaceuticals (NRXP) Return on Invested Capital (2021 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Return on Invested Capital for 3 consecutive years, with 0.13% the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.13% |
| Sep 30, 2024 | -0.16% |
| Sep 30, 2021 | -0.03% |